1-3 of 3
Huang Xuelin
Close
Sort by
Journal Articles

Superior Response Rates for Patients with Myeloid Malignancies Treated with the Combination of Decitabine (DAC) and Arsenic Trioxide (ATO) in a Phase II Adaptive Three Arm Randomization Study: DAC +/- Carboplatin or ATO

Patricia L. Kropf, MD, Philip A. Pancari, MD, Henry Fung, Hagop M. Kantarjian, MD, Lianchun Xiao, Huang Xuelin, Jean-Pierre Issa, MD
Journal: Blood
Blood (2015) 126 (23): 3775.
https://doi.org/10.1182/blood.V126.23.3775.3775
Published: 2015
Journal Articles

Ruxolitinib Reduces Cytokine/Chemokine Levels and Improves Fatigue and Chronic Lymphocytic Leukemia (CLL)-Related Symptoms in CLL Patients Not Requiring Systemic Therapy

Preetesh Jain, MBBS,MDDM,PhD, Michael J. Keating, MD, Charles Cleeland, Sarah Renner, Huang Xuelin, Graciela Nogueras Gonzalez, David M. Harris, William Wierda, MD PhD, Courtney DiNardo, MD, Naveen Pemmaraju, Nitin Jain, MD, Philip Thompson, MBBS, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD, Zeev Estrov, MD
Journal: Blood
Blood (2015) 126 (23): 2943.
https://doi.org/10.1182/blood.V126.23.2943.2943
Published: 2015
Journal Articles

Longer Follow-Up Of The Combination Of Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy For Patients Younger Than 61 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Aziz Nazha, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Huang Xuelin, Sangbum Choi, Guillermo Garcia-Manero, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Tapan M. Kadia, MD, Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Alessandra Ferrajoli, MD, Steven M. Kornblau, MD, Michael Andreeff, MD, PhD, Min Du, Mark Brandt, Stefan H. Faderl, MD
Journal: Blood
Blood (2013) 122 (21): 1451.
https://doi.org/10.1182/blood.V122.21.1451.1451
Published: 2013